Cisco Secure Access Control System Web interface cross-site scripting

cisco-acs-cve20133423-xss (85624) The risk level is classified as MediumMedium Risk


Cisco Secure Access Control System is vulnerable to cross-site scripting, caused by improper validation of user-supplied input by the Web interface. A remote attacker could exploit this vulnerability using an unspecified field to inject malicious script into a Web page which would be executed in a victim's Web browser within the security context of the hosting Web site, once the page is viewed. An attacker could use this vulnerability to steal the victim's cookie-based authentication credentials.


Base Score: 4.3
  Access Vector: Network
  Access Complexity: Medium
  Authentication: None
  Confidentiality Impact: None
  Integrity Impact: Partial
  Availability Impact: None
Temporal Score: 3.7
  Exploitability: High
  Remediation Level: Official-Fix
  Report Confidence: Confirmed


Cross-Site Scripting


Refer to Cisco Security Notice for patch, upgrade or suggested workaround information. See References.


  • Cisco Security Notice: Cisco Secure Access Control System Cross-Site Scripting Vulnerability .
  • BID-61173: Cisco Secure Access Control System CVE-2013-3423 Cross Site Scripting Vulnerability
  • CVE-2013-3423: Cross-site scripting (XSS) vulnerability in the web interface in Cisco Secure Access Control System (ACS) allows remote attackers to inject arbitrary web script or HTML via an unspecified field, aka Bug ID CSCud75174.
  • SA54200: Cisco Secure Access Control System Multiple Vulnerabilities

Platforms Affected:

  • Cisco Secure Access Control System


Jul 15, 2013

The information within this database may change without notice. Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. In no event shall the author/distributor (IBM Internet Security Systems X-Force) be held liable for any damages whatsoever arising out of or in connection with the use or spread of this information.

For corrections or additions please email ignore thisxforceignore this@ignore thisus.ignore thisibm.comignore this

Return to the main page